Literature DB >> 21366383

Altered T-cell and regulatory cell repertoire in patients with diffuse cutaneous systemic sclerosis.

G Papp1, I F Horvath, S Barath, E Gyimesi, S Sipka, P Szodoray, M Zeher.   

Abstract

OBJECTIVES: The aim of this study was to evaluate a wide spectrum of peripheral immune-competent cell types, reflecting overall disturbances in immune homeostasis, characteristic of systemic sclerosis (SSc). We also assessed visceral organ involvement and evaluated the relationship between cell proportions and clinical symptoms of the disease.
METHODS: Twenty-one patients with diffuse cutaneous SSc (dcSSc) and 15 healthy individuals participated in the study. Peripheral blood lymphocyte subgroups were quantified by flow cytometry, soluble cytokines were assessed by enzyme-linked immunosorbent assay (ELISA), serum complement levels were measured by nephelometry, and autoantibodies were determined by indirect immunofluorescence staining and ELISA technique. Functional tests of regulatory T (Treg) cells were also carried out.
RESULTS: Patients with SSc had higher percentages of activated CD3+/HLA-DR+ T cells. Comparing naive vs. memory subsets of CD4+ and CD8+ T cells, a shift towards central memory phenotype was observed in SSc. Natural killer (NK) and T-helper (Th)17 cell percentages were increased, while NKT, Th1, Treg type 1 (Tr1), and CD4+CD25+ Treg cell percentages were decreased in patients. Moreover, the suppressor activity of CD4+CD25+ Treg cells was lower in SSc. Negative correlations occurred between modified Rodnan skin score (MRSS) and Tr1 cell percentages and between complement levels and CD4+CD25+ Treg cells. We also found decreased interleukin (IL)-10 levels in SSc.
CONCLUSIONS: Our data suggest that the increased Th17/CD4+CD25+ Treg ratio and the altered regulatory function of CD4+CD25+ Treg cells play an important role in the development of SSc. Moreover, our study reveals the potential role of the decreased profile of IL-10-producing Tr1 cells in the progression of disproportionate immune responses in SSc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366383     DOI: 10.3109/03009742.2010.528021

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  32 in total

1.  Peripheral blood regulatory T cells in patients with diffuse systemic sclerosis (SSc) before and after autologous hematopoietic SCT: a pilot study.

Authors:  J Baraut; E I Grigore; F Jean-Louis; S H Khelifa; C Durand; F Verrecchia; D Farge; L Michel
Journal:  Bone Marrow Transplant       Date:  2013-12-23       Impact factor: 5.483

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

Review 3.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

4.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?

Authors:  Guillermo Carvajal Alegria; Pierre Gazeau; Sophie Hillion; Claire I Daïen; Divi Y K Cornec
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

6.  Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients.

Authors:  Lucas C M Arruda; Kelen C R Malmegrim; João R Lima-Júnior; Emmanuel Clave; Juliana B E Dias; Daniela A Moraes; Corinne Douay; Isabelle Fournier; Hélène Moins-Teisserenc; Antônio José Alberdi; Dimas T Covas; Belinda P Simões; Pauline Lansiaux; Antoine Toubert; Maria Carolina Oliveira
Journal:  Blood Adv       Date:  2018-01-23

7.  The effects of extracorporeal photochemotherapy on T cell activation and regulatory mechanisms in patients with systemic sclerosis.

Authors:  Gabor Papp; Sandor Barath; Andrea Szegedi; Peter Szodoray; Margit Zeher
Journal:  Clin Rheumatol       Date:  2012-06-16       Impact factor: 2.980

Review 8.  Cytokine Milieu in Undifferentiated Connective Tissue Disease: a Comprehensive Review.

Authors:  Britt Nakken; Edit Bodolay; Peter Szodoray
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

9.  Evaluation of membrane-bound and soluble forms of human leucocyte antigen-G in systemic sclerosis.

Authors:  P Contini; S Negrini; G Murdaca; M Borro; F Puppo
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

Review 10.  Autoantibodies in lung transplantation.

Authors:  Angara Sureshbabu; Timothy Fleming; Thalachallour Mohanakumar
Journal:  Transpl Int       Date:  2019-08-27       Impact factor: 3.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.